Group 1 - Honghua Digital intends to acquire 49% equity of Shandong Yingkejie for 105 million yuan, resulting in full ownership of the company, which specializes in industrial inkjet technology [1] - Xue Ren Group's metal plate fuel cell stack project has passed final acceptance, delivering complete technical documentation and meeting performance requirements [2] - PIANO's controlling shareholder is planning a change in control, leading to a temporary suspension of its stock [3] Group 2 - COSCO SHIPPING Specialised Carriers plans to invest 258 million yuan in Shenshan Port Investment Company, acquiring a 20% stake [4] - Jieshun Technology has won a management project for an underground parking lot, expecting over 70 million yuan in revenue by the end of the contract in 2031 [5] - Aerospace Rainbow is collaborating with Zhongtian Rocket to establish a company focused on artificial weather modification technology with a total investment of 50 million yuan [6] Group 3 - Purun Co. intends to acquire 49% equity of Nuoya Changtian through a combination of shares, convertible bonds, and cash, making it a wholly-owned subsidiary [7] - Dongfang Yuhong plans to sell a commercial property for 10.12 million yuan, expecting a significant asset disposal loss [8] - Tianqi Lithium is applying for designated delivery warehouse qualifications for lithium hydroxide at the Guangzhou Futures Exchange [9] Group 4 - Tianfu Communication is planning to issue H-shares on the Hong Kong Stock Exchange, with details yet to be finalized [10] - ST Yishite's controlling shareholder will transfer 4.18 million shares to Hubei Jingjiang Industrial Investment Group, changing the actual controller to the Jingzhou State-owned Assets Supervision and Administration Commission [11] - Dongwei Technology's directors and key technical personnel plan to reduce their holdings by up to 1.11% of the company's shares [12] Group 5 - Guojin Securities shareholders plan to reduce their holdings by a total of 0.72% of the company's shares [23] - Hongde Co. controlling shareholder and associated parties plan to reduce their holdings by up to 3% [24] - Aopu Mai's restructuring plan to acquire 100% of Pengli Bio has been approved by the exchange [26] Group 6 - Kosen Technology intends to sell 100% of Kosen Medical for 915 million yuan due to challenges in its business environment [28] - Rongsheng Petrochemical's subsidiary plans to transfer 100% of Rongsheng Energy (Zhoushan) to Rongsheng Holdings [29] - Jingji Zhino reported a cumulative sales revenue of 3.464 billion yuan from pig sales in the first 11 months of 2025 [30]

Core Viewpoint - Kosen Medical, established in July 2018 with a registered capital of 118 million yuan, is facing challenges in its business development due to external market changes and ongoing Sino-U.S. trade tensions, with limited synergy with its core operations [1] Group 1: Company Overview - Kosen Medical primarily engages in the processing and export of minimally invasive surgical instruments [1] - The company will no longer be included in the consolidated financial statements following the completion of the transaction with Yaolingke, a wholly-owned subsidiary of FSP Holdings Pte. Ltd [1] Group 2: Transaction Details - The transaction is expected to increase the company's investment income by approximately 600 million yuan in the fiscal year 2025, aiding in cash flow recovery and reducing financial pressure [1] - Proceeds from the transaction will be used to supplement working capital, aiming to optimize the company's asset structure and fully exit the medical business [1] Group 3: Strategic Focus - Kosen Technology, the parent company, focuses on precision die-casting, forging, stamping, CNC, and laser cutting processes, providing precision structural components for well-known international clients such as Apple, Huawei, Amazon, and Google [1] - The strategic shift aims to further concentrate on the consumer electronics sector, enhancing operational levels and quality [1]

Group 1 - The company Kosen Technology (603626.SH) plans to sell its wholly-owned subsidiary Kosen Medical for 915 million yuan to Jiangsu Yaoling Medical Technology Co., Ltd [1][2] - Kosen Medical specializes in the processing and export of minimally invasive surgical instruments, but has faced challenges due to external market conditions and Sino-U.S. trade tensions [1][2] - The technology path and customer base of Kosen Medical differ significantly from the company's core business, resulting in limited synergy [1][2] Group 2 - The decision to sell the subsidiary is part of the company's strategy to optimize asset allocation and focus on its main business and emerging industries [1][2]

Group 1 - The core point of the article is that Kosen Technology (SH 603626) announced the cancellation of its supervisory board and the revision of its articles of association during a board meeting held on December 8, 2025 [1] - Kosen Technology's revenue composition for the year 2024 is as follows: 76.75% from mobile and tablet structural components, 10.58% from new energy-storage business, 8.1% from medical surgical instrument structural components, 3.33% from general precision metal structural components, and 1.23% from other businesses [1] - As of the report date, Kosen Technology has a market capitalization of 7.5 billion yuan [1]

Core Viewpoint - Company Kosen Technology (603626.SH) announced the sale of its 100% stake in Kosen Medical to Yaolingke for a consideration of 915 million RMB, achieving a value increase of 206.45% [1] Group 1: Transaction Details - The transaction will result in Kosen Technology no longer holding any equity in Kosen Medical, which will be excluded from the company's consolidated financial statements [1] - Kosen Medical, established in July 2018 with a registered capital of 118 million RMB, is a wholly-owned subsidiary primarily engaged in the processing and export of minimally invasive surgical instruments [1] Group 2: Strategic Rationale - The decision to divest Kosen Medical is driven by challenges faced due to external market changes and ongoing Sino-U.S. trade tensions, impacting its business development [1] - Kosen Medical's technology pathways and customer base differ from the core business of Kosen Technology, resulting in limited synergy [1] - The sale aims to optimize the overall asset allocation, divest non-core businesses, focus on the main industry and emerging sectors, and ensure sustainable business development while improving company performance [1] Group 3: Compliance and Transaction Nature - The buyer, Yaolingke, is not a related party of Kosen Technology, and the equity transfer does not constitute a related party transaction according to the Shanghai Stock Exchange listing rules [1]

公司本次对外转让科森医疗100%股权，主要目的为公司拟全面退出医疗业务，进一步聚焦消费电子主 业，提升公司的经营水平和质量，符合公司长远发展的战略规划。本次股权转让有利于实现资金回笼， 降低公司资金压力，所获得的款项将用于补充公司流动资金，用于公司日常生产经营。 科森科技（603626）(603626.SH)发布公告，为进一步优化公司资产结构，结合自身战略规划和业务发 展情况，公司拟以9.15亿元人民币的对价将其持有的科森医疗100%的股权转让给耀岭科，增值率 206.45%。本次交易完成后，公司将不再持有科森医疗股权，科森医疗不再纳入公司的合并报表范围。 ...

智通财经APP讯，科森科技(603626.SH)发布公告，为进一步优化公司资产结构，结合自身战略规划和 业务发展情况，公司拟以9.15亿元人民币的对价将其持有的科森医疗100%的股权转让给耀岭科，增值 率206.45%。本次交易完成后，公司将不再持有科森医疗股权，科森医疗不再纳入公司的合并报表范 围。 公司本次对外转让科森医疗100%股权，主要目的为公司拟全面退出医疗业务，进一步聚焦消费电子主 业，提升公司的经营水平和质量，符合公司长远发展的战略规划。本次股权转让有利于实现资金回笼， 降低公司资金压力，所获得的款项将用于补充公司流动资金，用于公司日常生产经营。 ...

本资产评估报告依据中国资产评估准则编制 昆山科森科技股份有限公司拟股权转让所涉及的 江苏科森医疗器械有限公司股东全部权益价值 资产评估报告 金证评报字【2025】第 0725 号 (共一册, 第一册) 金证（上海）资产评估有限公司 2025 年 12 月 7 日 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 3132020024202500728 | | --- | --- | | 合同编号: | 金证评合约字【2025】第09041号 | | 报告类型: | 非法定评估业务资产评估报告 | | 报告文号: | 金证评报字 2025】第0725号 | | 报告名称: | 昆山科委科技股份有限公司拟股权等让所涉及的江苏科瑞医疗布 械有限公司股东全部权益价值资产评估报告 | | 评估结论: | 913.000.000.00元 | | 评估报告日: | 2025年12月07日 | | 评估机构名称: | 金证(上海)资产评估有限公司 | | 签名人员: | 正式会员 编号: 31190140 马翊君 (资产评估师) | | | 正式会员 编号:31190143 (资产评估师) 刘怡青 | 马翊君、 ...

中国・北京 BEIJING CHINA 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查理 报告编码:京251VB26MRA 目 | 一、审计报告 | 1-2 | | --- | --- | | 二、已审财务报表 | | | 1. 合并资产负债表 | 1-2 | | 2. 合并利润表 | 3 | | 3. 合并现金流量表 | 4 | | 4. 合并所有者权益变动表 | 5—6 | | 5. 资产负债表 | 7-8 | | 6. 利润表 | 9 | | 7. 现金流量表 | 10 | | 8. 所有者权益变动表 | 11-12 | | 9. 财务报表附注 | 13—52 | 中审亚太会计师事务所(特殊普通合伙) China Audit Asia Pacific Certified Public Accountants LLP 十十 报 告 AUDIT REPORT 江苏科森医疗器械有限公司 2025 年 1-9 月财务报表审计 China Audit Asia Pacific Certified Public Accountants LLP 审计报告 ...

Core Viewpoint - The company, Kosen Technology (603626.SH), plans to sell its wholly-owned subsidiary, Kosen Medical Devices, to Jiangsu Yaolingke Medical Technology Co., Ltd. for a total transaction amount of 915 million yuan [1] Group 1: Transaction Details - The sale involves 100% equity of Kosen Medical, which primarily engages in the processing and export of minimally invasive surgical instruments [1] - The transaction amount is set at 915 million yuan [1] Group 2: Business Challenges - Kosen Medical has faced challenges in its business development due to changes in the external market environment and ongoing Sino-U.S. trade tensions [1] - The subsidiary's technology path and customer base differ from the company's core business, resulting in limited synergy [1] Group 3: Strategic Decision - The company aims to optimize its overall asset allocation by divesting non-core businesses and focusing on its main operations and emerging industries [1]